113 related articles for article (PubMed ID: 2983968)
21. Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure.
Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
J Hypertens Suppl; 1983 Oct; 1(1):147-53. PubMed ID: 6100604
[TBL] [Abstract][Full Text] [Related]
22. Hormone and haemodynamic effects of angiotensin II infusion during captopril treatment for heart failure.
Chambers S; Nicholls MG; Espiner EA; Ikram H; Livesey JH
Horm Metab Res; 1985 Mar; 17(3):159-62. PubMed ID: 2987094
[TBL] [Abstract][Full Text] [Related]
23. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
24. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
25. [The effect of captopril on hemodynamics in patients of chronic obstructive pulmonary disease with pulmonary hypertension].
Wang S
Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):545-8. PubMed ID: 8269786
[TBL] [Abstract][Full Text] [Related]
26. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
Maslowski AH; Ikram H; Nicholls MG; Espiner EA
Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
[TBL] [Abstract][Full Text] [Related]
27. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
Silberbauer K; Punzengruber C; Sinzinger H
Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
[TBL] [Abstract][Full Text] [Related]
28. Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction.
McAlpine HM; Morton JJ; Leckie B; Dargie HJ
J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S25-30. PubMed ID: 2441196
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
Packer M; Medina N; Yushak M
Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
[TBL] [Abstract][Full Text] [Related]
32. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
[TBL] [Abstract][Full Text] [Related]
33. Plasma free captopril concentrations during short and long term treatment with oral captopril for heart failure.
Shaw TR; Duncan FM; Williams BC; Crichton E; Thomson SA; Davis JR; Rademaker M; Edwards CR
Br Heart J; 1985 Aug; 54(2):160-5. PubMed ID: 3893490
[TBL] [Abstract][Full Text] [Related]
34. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Weiner DA; Ryan TJ
Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
[TBL] [Abstract][Full Text] [Related]
35. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
Levine TB; Olivari MT; Cohn JN
Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
[TBL] [Abstract][Full Text] [Related]
37. [A clinical study of intravenous captopril in heart failure].
Wu H; Zhao HY
Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):161-4. PubMed ID: 8222978
[TBL] [Abstract][Full Text] [Related]
38. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
[TBL] [Abstract][Full Text] [Related]
39. Improvement of chronic congestive heart-failure by oral captopril.
Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H
Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679
[TBL] [Abstract][Full Text] [Related]
40. Haemodynamic, radionuclide ventriculography and ergometric evaluation of captopril treatment in congestive heart failure.
Gronda E; Brusoni B; Mangiavacchi M; Oppizzi M; Inglese E; Caroli A; Rovelli F
Postgrad Med J; 1986; 62 Suppl 1():167-9. PubMed ID: 3534856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
